SCHEMBL7884342

SCHEMBL7884342

COc1ccc(C)c2cc(C(=O)N(C(=N)N)C(C)C)[nH]c12.CS(=O)(=O)O

nearest known ligand 0.43

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.43
HPGD P15428 3/20 0.43
ALDH1A1 P00352 10/20 0.39
HSD17B10 Q99714 5/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
POLB P06746 2/20 0.37
LMNA P02545 1/20 0.37
MAPK1 P28482 1/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
KLF5 Q13887 2/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
TP53 P04637 1/20 0.35
SLC9A1 P19634 1/20 0.35
CYP2C9 P11712 2/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7873281 0.87 KDM4E (0.44) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL7873667 0.83 KDM4E (0.40) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL7882009 0.81 KDM4E (0.49) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL7877809 0.80 TOP2A (0.34) KDM4EHPGDALDH1A1HSD17B10TSHR
Hydrochloric Acid SCHEMBL7880940 0.80 KDM4E (0.48) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL7877778 0.77 KDM4E (0.44) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL7884346 0.76 KDM4E (0.42) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL7873287 0.75 KDM4E (0.45) KDM4EHPGDALDH1A1HSD17B10KMT2A
SCHEMBL7877586 0.74 KDM4E (0.42) KDM4EHPGDALDH1A1HSD17B10KMT2A
SCHEMBL7877526 0.73 BRD4 (0.33) KDM4EHPGDHSD17B10KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed